PPT-ADVANCES IN THERAPY FOR SARCOMA AND GIST

Author : ellena-manuel | Published Date : 2018-12-19

Angela Cioffi MD Sarcoma Research Program coordinator Mount Sinai Hospital NY USA Istituto Europeo di Oncologia IRCSS Milan Italy Today s job Review some

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "ADVANCES IN THERAPY FOR SARCOMA AND GIST" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

ADVANCES IN THERAPY FOR SARCOMA AND GIST: Transcript


Angela Cioffi MD Sarcoma Research Program coordinator Mount Sinai Hospital NY USA Istituto Europeo di Oncologia IRCSS Milan Italy Today s job Review some of the key studies sarcoma that dictate present management. Evidence-based Management . of GIST. Program Goals. GIST. Current Treatment Paradigm. What is GIST?. What Causes GIST?. GIST: Treatment. Polling Question #1. Imatinib: Clinical Trial Results. Imatinib: Early Stage GIST. . University. of Bologna . Advances. in . cancer. target . pathways. . Roma 8 aprile 2016. Targeting. . molecular. . pathways. . in GIST . La . risposta. ad . imatinib. . dipende. (aka---how to know where to look and who to call). GIST. Rare disease, 5000-7000 new cases of GIST every year . Compare 230,000 new invasive breast CA cases/year. GIST studies tend to be opened at fewer sites . Translation. Unit 1. 1.1 Basic Definitions. To realize what the translator does in the process of translation, we must clarify a number of terms that will be used throughout the course: . Text: . Any stretch of speech or writing assumed to make a coherent whole. . Tim Bowersox, Cyril Oberlander, Kate Pitcher, Mark Sullivan. State University of New York, Geneseo College. Getting It System Toolkit. Enhancing user experience. and customizing a future for ILL & Acquisition. Seth M. Pollack, . MD. Associate in Clinical Research, . Fred Hutchinson Cancer Research Center. Acting Instructor, University of Washington. Cancer immunology review. :. Sarcoma Cell. Tumor specific proteins are composed of peptides. Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing sarcoma : An Interim Update Edwin Choy, Gregory Cote, James Butrynski, David Harmon, Suzanne George, Andrew Wagner, Jeffrey Morgan, David D’Adamo, George Demetri cooperative migration strategies. NE-ASIS&T December 8, 2009. Cyril Oberlander, Associate Director. State University of New York, Geneseo. Cyril@geneseo.edu. . Community Celebration of Life. A cooperative strategic wake for moving from the living dead metaphors to sharing a new library. . SYFTET. Göteborgs universitet ska skapa en modern, lättanvänd och . effektiv webbmiljö med fokus på användarnas förväntningar.. 1. ETT UNIVERSITET – EN GEMENSAM WEBB. Innehåll som är intressant för de prioriterade målgrupperna samlas på ett ställe till exempel:. Tim Bowersox, Cyril Oberlander, Kate Pitcher, Mark Sullivan. State University of New York, Geneseo College. Getting It System Toolkit. Charleston Conference. November 2009. What is GIST?. A system for:. James Hays. cs195g Computational Photography. Brown University, Spring 2010. Recap from Monday. What imagery is available on the Internet. What different ways can we use that imagery. aggregate statistics. Shiela S. Macalindong, MD, FPCS, FACS. Clinical Associate Professor. Division of Surgical Oncology, Head and Neck, Breast, Skin & Soft Tissue, and Esophagogastric Surgery. SOFT TISSUE MASSES. Most are benign. : . The Next Generation. Dr. Michael Heinrich, M.D. OHSU Knight Cancer Institute. Portland, OR. Background. Small molecule . kinase. inhibitors of KIT/PDGFRA such as imatinib and sunitinib have transformed the medical treatment of advanced GIST. Gareth Ayre. SWAG Sarcoma SSG. 12. th. Feb, 2019. Rationale for new service spec. Variation in how SAGs function – lack of robust referral / treatment pathways and their oversight. Some patients may not get the most appropriate treatment from the most appropriate team.

Download Document

Here is the link to download the presentation.
"ADVANCES IN THERAPY FOR SARCOMA AND GIST"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents